Holen Sie sich die Stockscreener-App
9.2881
0.33%
0.0581
Schlusskurs vom Vortag:
$9.23
Offen:
$9.2
24-Stunden-Volumen:
172.59K
Relative Volume:
0.44
Marktkapitalisierung:
$1.33B
Einnahmen:
$6.32B
Nettoeinkommen (Verlust:
$230.14M
KGV:
9.6771
EPS:
0.9598
Netto-Cashflow:
$256.03M
1W Leistung:
-5.51%
1M Leistung:
-4.44%
6M Leistung:
+2.32%
1J Leistung:
-36.66%
1-Tages-Spanne:
$8.985
$9.335
1-Wochen-Bereich:
$8.985
$9.77
52-Wochen-Spanne:
$8.07
$15.48
Ardent Health Inc Stock (ARDT) Company Profile
Firmenname
Ardent Health Inc
Sektor
Branche
Telefon
(615) 296-3000
Adresse
340 SEVEN SPRINGS WAY, BRENTWOOD
Compare ARDT vs HCA, THC, DVA, FMS, EHC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ARDT
Ardent Health Inc
|
9.28 | 1.32B | 6.32B | 230.14M | 256.03M | 0.9598 |
HCA
Hca Healthcare Inc
|
393.74 | 87.42B | 76.39B | 7.81B | 7.93B | 29.08 |
THC
Tenet Healthcare Corp
|
178.80 | 14.97B | 21.46B | 2.65B | 3.35B | 19.23 |
DVA
Davita Inc
|
196.08 | 12.74B | 13.84B | 1.10B | 1.49B | 10.42 |
FMS
Fresenius Medical Care Ag Adr
|
21.64 | 11.62B | 22.18B | 1.36B | 2.00B | 1.9216 |
EHC
Encompass Health Corp
|
105.42 | 10.41B | 6.07B | 793.80M | 464.40M | 5.9914 |
Ardent Health Inc Stock (ARDT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-17 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2025-11-14 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-10-14 | Eingeleitet | Goldman | Neutral |
| 2025-09-10 | Eingeleitet | UBS | Buy |
| 2025-07-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2024-12-17 | Fortgesetzt | JP Morgan | Neutral |
| 2024-11-06 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-08-12 | Eingeleitet | BofA Securities | Buy |
| 2024-08-12 | Eingeleitet | Citigroup | Buy |
| 2024-08-12 | Eingeleitet | JP Morgan | Neutral |
| 2024-08-12 | Eingeleitet | Leerink Partners | Outperform |
| 2024-08-12 | Eingeleitet | Loop Capital | Buy |
| 2024-08-12 | Eingeleitet | Mizuho | Outperform |
| 2024-08-12 | Eingeleitet | Morgan Stanley | Overweight |
| 2024-08-12 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2024-08-12 | Eingeleitet | Stephens | Overweight |
| 2024-08-12 | Eingeleitet | Truist | Buy |
Alle ansehen
Ardent Health Inc Aktie (ARDT) Neueste Nachrichten
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ardent Health, Inc. (ARDT) and Encourages Stockholders to Learn More About the Investigation - ACCESS Newswire
A Quick Look at Today's Ratings for Ardent Health(ARDT.US), With a Forecast Between $12 to $13.5 - Moomoo
Bronstein, Gewirtz & Grossman, LLC Is Investigating Ardent Health, Inc. (ARDT) And Encourages Shareholders to Connect - ACCESS Newswire
Ardent Health, Inc. (ARDT) Investigation: Bronstein, Gewirtz & Gr - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc - The National Law Review
How Investors Are Reacting To Ardent Health (ARDT) Fujifilm Synapse Imaging Integration Across Hospitals - Sahm
Ardent Health and Fujifilm team up for Synapse enterprise imaging rollout - MSN
Analysts Offer Insights on Healthcare Companies: Aquestive Therapeutics (AQST) and Ardent Health Partners, Inc. (ARDT) - The Globe and Mail
Leerink Partners Maintains Ardent Health(ARDT.US) With Buy Rating, Cuts Target Price to $14 - Moomoo
Ardent doctors get anytime, anywhere access to scans via Fujifilm deal - Stock Titan
Ardent Health Looking for M&A - marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Ardent Health, Inc. (ARDT) And Encourages Shareholders to Reach Out - ACCESS Newswire
2026-05-12 | Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Ardent Health, Inc. (ARDT) And Encourages Shareholders to Reach Out | NYSE:ARDT | Press Release - Stockhouse
Ardent Health Q1 2026 slides show 26% EBITDA growth amid challenges - Investing.com Canada
Earnings call transcript: Ardent Health Q1 2026 sees revenue growth but misses EPS forecast - Investing.com Canada
How 5 health systems are getting ahead of pending Medicaid cuts - Modern Healthcare
Ardent Health Earnings Call Highlights Margin Momentum - TipRanks
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Ardent Health, Inc. (ARDT) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Ardent Health, Inc. 2026 Q1ResultsEarnings Call Presentation (NYSE:ARDT) 2026-05-09 - Seeking Alpha
Ardent outlines $55M impact savings target while completing 2,000-room hellocare.ai rollout by year-end - MSN
Ardent Health (ARDT) Margin Compression To 2.1% Reinforces Bearish Profitability Concerns - Sahm
Results: Ardent Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - simplywall.st
Earnings Beat: Ardent Health, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Yahoo Finance
Ardent Health, Inc. (ARDT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
symbol__ Stock Quote Price and Forecast - CNN
Ardent Health Q1 Earnings Call Highlights - Yahoo Finance
[10-Q] Ardent Health, Inc. Quarterly Earnings Report - Stock Titan
Ardent Health (ARDT) Q1 2026 Earnings Transcript - AOL.com
Ardent Health Q1 2026 slides: 26% EBITDA growth, stock falls By Investing.com - Investing.com Canada
Earnings call transcript: Ardent Health Q1 2026 sees 7% revenue growth - Investing.com Canada
Transcript: Ardent Health Partners Q1 2026 Earnings Conference Call - Benzinga
BofA raises Ardent Health stock price target on strong Q1 results By Investing.com - Investing.com Australia
Ardent Health Partners, LLC Q1 2026 Earnings Call Summary - Yahoo Finance
BofA raises Ardent Health stock price target on strong Q1 results - Investing.com UK
What Ardent Health (ARDT)'s Q1 2026 EBITDA Jump and Reaffirmed Outlook Mean For Shareholders - simplywall.st
Bronstein, Gewirtz & Grossman, LLC Is Investigating Ardent Health, Inc. (ARDT) And Encourages Investors to Connect - ACCESS Newswire
Ardent Health, Inc. (ARDT) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance
Ardent Health (NYSE:ARDT) Stock Rises on Q1 Earnings Beat and Strong Margin Growth - ChartMill
Ardent Health | 8-K: Ardent Health Reports First Quarter 2026 Results - Moomoo
ARDENT HEALTH PARTNERS ($ARDT) Releases Q1 2026 Earnings, Stock Rises - Quiver Quantitative
Earnings Flash (ARDT) Ardent Health, Inc. Reports Q1 Revenue $1.60B, vs. FactSet Est of $1.58B - marketscreener.com
Ardent Health Q1 revenue rises 7%, beats estimates - TradingView
Weather hit patient volumes, but Ardent kept its 2026 forecast - Stock Titan
Ardent Health (NYSE: ARDT) posts Q1 growth and reaffirms 2026 outlook - Stock Titan
Ardent Health, Inc. Reaffirms Earnings Guidance for the Year 2026 - marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Encourages Ardent Health, Inc. (ARDT) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
ARDT SEC FilingsArdent Health 10-K, 10-Q, 8-K Forms - Stock Titan
Ardent Health Inc expected to post earnings of 18 cents a shareEarnings Preview - TradingView
Ardent Health to Participate in the Bank of America 2026 Healthcare Conference - marketscreener.com
Ardent Health management goes live from Las Vegas on May 13 - Stock Titan
Stephens & Co. Maintains Ardent Health (ARDT) Overweight Recommendation - MSN
Finanzdaten der Ardent Health Inc-Aktie (ARDT)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.10%
0.00%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):